Treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). It is indicated for: Patients who have not yet received chemotherapy (asymptomatic or mildly symptomatic). Patients whose disease has progressed on or after docetaxel therapy.

Dosage and administration

Recommended Daily Dose: 160 mg once daily. 💊 Since each capsule contains 40 mg, you must take 4 capsules at once. Administration: Take orally with or without food. Swallow capsules whole with water. Do not chew, dissolve, or open the capsules. Take at the same time each day.

Hypersensitivity to Enzalutamide. History of Seizures: Use with caution in patients with a history of seizures or predisposing factors (brain injury, stroke), as the drug may lower the seizure threshold. Women who are or may become pregnant.

Generally well-tolerated compared to chemotherapy. Common side effects include: Fatigue (Asthenia) — most common. Hot flushes. Headache. Hypertension (High blood pressure). Increased risk of falls or fractures. Seizure Risk: Discontinue permanently if a seizure occurs during treatment.

Bdenza — Enzalutamide 40 mg, 112 pcs, BDR

100% original product

Active ingredient

Enzalutamide

Manufacturer

BDR

Dosage 40 mg

Dosage form Capsules

Capsules per pack 112

Bdenza (Enzalutamide) 40 mg

8526₴ ~~9669₴~~ -12%

Bdenza is a next-generation anti-androgen medication used to treat advanced prostate cancer. Active ingredient: Enzalutamide (40 mg).

Manufacturer: BDR Pharmaceuticals (India). It is a cost-effective generic version of the brand drug Xtandi.

Key Advantages over Abiraterone (Zytiga):

✅ No Steroids Required: Unlike Abiraterone, Bdenza does not require co-administration with prednisone, avoiding steroid-related side effects.
✅ Flexible Dosing: Can be taken with or without food.
✅ Triple Mechanism: Inhibits androgen binding, prevents nuclear translocation, and blocks DNA binding.

Treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).

It is indicated for:

Patients who have not yet received chemotherapy (asymptomatic or mildly symptomatic).
Patients whose disease has progressed on or after docetaxel therapy.

Recommended Daily Dose: 160 mg once daily.

💊 Since each capsule contains 40 mg, you must take 4 capsules at once.

Administration:

Take orally with or without food.
Swallow capsules whole with water. Do not chew, dissolve, or open the capsules.
Take at the same time each day.

Hypersensitivity to Enzalutamide.
History of Seizures: Use with caution in patients with a history of seizures or predisposing factors (brain injury, stroke), as the drug may lower the seizure threshold.
Women who are or may become pregnant.

Generally well-tolerated compared to chemotherapy. Common side effects include:

Fatigue (Asthenia) — most common.
Hot flushes.
Headache.
Hypertension (High blood pressure).
Increased risk of falls or fractures.

Seizure Risk: Discontinue permanently if a seizure occurs during treatment.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 23.03.2026